Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Unicycive Therapeutics Q2 EPS $(0.13) Down From $(0.04) YoY

Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.13) per share. This is a 225 percent decrease over losses of $(0.04) per share from the same period last year.

byBenzinga Newsdesk

August 16, 2021

1 minute read

Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.13) per share. This is a 225 percent decrease over losses of $(0.04) per share from the same period last year.